EFFICACY AND SAFETY OF AUTOMATED INSULIN DELIVERY SYSTEMS AND SENSOR-AUGMENTED PUMP THERAPY WITH PREDICTIVE LOW GLUCOSE MANAGEMENT IN AN ELDERLY POPULATION WITH TYPE 1 DIABETES

被引：0
|
作者：
Medina, A. Gomez [1 ]
Parra, D. [1 ]
Carrillo, D. Henao [1 ]
Gomez, C. [1 ]
机构：
[1] Hosp Univ San Ignacio, Endocrinol Unit, Bogota, Colombia
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1018
引用
收藏
页码：A258 / A258
页数：1
相关论文
共 50 条
  • [31] INCORPORATION OF THE SENSOR-AUGMENTED INSULIN-PUMP THERAPY INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR
    Visentin, R.
    Vettoretti, M.
    Facchinetti, A.
    Dalla Man, C.
    Sparacino, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A130 - A130
  • [32] PATIENT TIME AND INDIRECT COSTS ASSOCIATED WITH SENSOR-AUGMENTED INSULIN PUMP THERAPY IN TYPE 1 DIABETES
    Kamble, S.
    Weinfurt, K. P.
    Perry, B. M.
    Schulman, K. A.
    Reed, S. D.
    VALUE IN HEALTH, 2011, 14 (03) : A84 - A84
  • [33] Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes
    Maria Gomez, Ana
    Marin Carrillo, Lisseth Fernanda
    Munoz Velandia, Oscar Mauricio
    Rondon Sepulveda, Martin Alonso
    Arevalo Correa, Carol M.
    Mora Garzon, Edwin
    Cuervo Diaz, Maria Camila
    Henao Carrillo, Diana Cristina
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (02) : 109 - 114
  • [34] Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes (The STAR 3 Study)
    Gimenez Alvarez, M.
    AVANCES EN DIABETOLOGIA, 2010, 26 (05): : 383 - 384
  • [35] 7.5 Reduction of Severe Hypoglycemia with Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension in Patients with Type 1 Diabetes (228-OR)
    Trang T. Ly
    Jennifer A. Nicholas
    Adam Retterath
    Ee Mun Lim
    Elizabeth A. Davis
    Timothy W. Jones
    Nederlands Tijdschrift voor Diabetologie, 2013, 11 (3) : 101 - 101
  • [36] Routine Sensor-Augmented Pump Therapy in Type 1 Diabetes: The INTERPRET Study
    Norgaard, Kirsten
    Scaramuzza, Andrea
    Bratina, Natasa
    Lalic, Nebojsa M.
    Jarosz-Chobot, Przemyslaw
    Kocsis, Gyozo
    Jasinskiene, Edita
    De Block, Christophe
    Carrette, Odile
    Castaneda, Javier
    Cohen, Ohad
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (04) : 273 - 280
  • [37] Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study
    Picard, Sylvie
    Hanaire, Helene
    Baillot-Rudoni, Sabine
    Gilbert-Bonnemaison, Elisabeth
    Not, Didier
    Reznik, Yves
    Guerci, Bruno
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (03) : 127 - 135
  • [38] The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study
    Akihiro Katayama
    Atsuhito Tone
    Mayu Watanabe
    Sanae Teshigawara
    Satoshi Miyamoto
    Jun Eguchi
    Atsuko Nakatsuka
    Kenichi Shikata
    Jun Wada
    Diabetology International, 2020, 11 : 97 - 104
  • [39] The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study
    Katayama, Akihiro
    Tone, Atsuhito
    Watanabe, Mayu
    Teshigawara, Sanae
    Miyamoto, Satoshi
    Eguchi, Jun
    Nakatsuka, Atsuko
    Shikata, Kenichi
    Wada, Jun
    DIABETOLOGY INTERNATIONAL, 2020, 11 (02) : 97 - 104
  • [40] Factors associated with clinically significant hypoglycemia in patients with type 1 diabetes using sensor-augmented pump therapy with predictive low-glucose management: A multicentric study on iberoamerica
    Gomez, Ana M.
    Imitola, Angelica
    Henao, Diana
    Garcia-Jaramillo, Maira
    Gimenez, Marga
    Vinals, Clara
    Grassi, Bruno
    Torres, Mariana
    Zuluaga, Isabella
    Munoz, Oscar Mauricio
    Rondon, Martin
    Leon-Vargas, Fabian
    Conget, Ignacio
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (01) : 267 - 272
12345